Cerebral astroblastoma in an adult: An immunohistochemical, ultrastructural and genetic study

Neuropathology

Volumn 33, Issue 3, 2013, Pages 312-319

  Fu, Yong Juan ^a   Taniguchi, Yoshinori ^b   Takeuchi, Shigekazu ^b   Shiga, Atsushi ^a   Okamoto, Kouichirou ^a   Hirato, Junko ^c   Nobusawa, Sumihito ^d   Nakazato, Yoichi ^d   Kakita, Akiyoshi ^a   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Nagaoka Chuo General Hospital   (Japan)

^c GUNMA UNIVERSITY HOSPITAL   (Japan)

^d GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Astroblastoma; Ependymal differentiation; Histogenesis; IDH1 2; TP53

Indexed keywords

CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NEUROSERPIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN S 100; VIMENTIN;

ADULT; ARM WEAKNESS; ARTICLE; BRAIN MITOCHONDRION; CANCER SURGERY; CASE REPORT; CELL SURFACE; CELL ULTRASTRUCTURE; CEREBRAL ASTROBLASTOMA; COMPUTER ASSISTED TOMOGRAPHY; CYTOPLASM; DISEASE DURATION; DNA SEQUENCE; EXTRACELLULAR SPACE; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HEMIPARESIS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT; LIMB WEAKNESS; MEDICAL HISTORY; MICROVILLUS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RARE DISEASE; ROUGH ENDOPLASMIC RETICULUM; SCLEROSIS; TUMOR CELL; TUMOR RECURRENCE;

BRAIN NEOPLASMS; DNA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOCITRATE DEHYDROGENASE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; NEUROSURGICAL PROCEDURES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878648765     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01351.x     Document Type: Article

References (43)

1. Aldape KD, Rosenblum IK. Astroblatoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds). WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARCP, 2007; 88-89.
2. Bonnin JM, Rubinstein LJ. Astroblastomas: A pathological study of 23 tumors, with a postoperative follow-up in 13 patients. Neurosurgery 1989; 25: 6-13.
3. Thiessen B, Finlay J, Kulkarni R, Rosenblum MK. Astroblastoma: does histology predic biologic behavior? J Neurooncol 1998; 40: 59-65.
4. Brat DJ, Hirose Y, Cohen KJ, Feuerstein BG, Burger PB. Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol 2000; 10: 342-352.
5. Navarro R, Reitman AJ, Goldman S, Marymont M, Tomita T. Astroblastoma in childhood: pathological and clinical analysis. Childs Nerv Syst 2005; 21: 211-220.
6. Salvati M, D'Elia A, Brogna C etal. Cerebral astroblastoma: analysis of six cases and critical review of treatment options. J Neurooncol 2009; 93: 369-378.
7. Ohgaki H, Dessen P, Jourde B etal. Genetic pathways to glioblatoma: a population-based study. Cancer Res 2004; 64: 6892-6899.
8. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 2009; 174: 1149-1153.
9. Sughrue ME, Choi J, Rutkowski MJ etal. Clinical features and post-surgical outcome of patients with astroblastomas. J Clin Neurosci 2011; 18: 750-754.
10. Port JD, Brat DJ, Burger PC, Pomper MG. Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma. AJNR Am J Neuroradiol 2002; 23: 243-247.
11. Bell JW, Osborn AG, Salzman KL, Blaser SI, Jones BV, Chin SS. Neuroradiologic characteristics of astroblastoma. Neuroradiology 2007; 49: 203-209.
12. Niazi TN, Jensen EM, Jensen RL. WHO grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol 2009; 91: 323-328.
13. Van Gompel JJ, Koeller KK, Meyer FB etal. Cortical ependymoma: an unusual epileptogenic lesion. J Neurosurg 2011; 114: 1187-1194.
14. Cabello A, Madero S, Castresana A, Diaz-Lobato R. Astroblastoma: electron microscopy and immunohistichemical findings: case report. Surg Neurol 1991; 35: 116-121.
15. Jay V, Edwards V, Squire J, Rutka J. Astroblastoma: report of a case with ultrastructural, cell kinetic, and cytogenetic analysis. Pediatr Pathol 1993; 13: 323-332.
16. Sugita Y, Terasaki M, Shigemori M, Morimatsu M, Honda E, Oshima Y. Astroblastoma with unusual signet-ring-like cell components: a case report and literature review. Neuropathology 2002; 22: 200-205.
17. Kim DS, Park SY, Lee SP. Astroblastoma: a case report. J Korean Med Sci 2004; 19: 772-776.
18. Kaji M, Takeshima H, Nakazato Y, Kuratsu J. Low-grade astroblastoma recurring with extensive invasion. Neurol Med Chir (Tokyo) 2006; 46: 450-454.
19. Kubota T, Sato K, Arishima H, Takeuchi H, Kitai R, Nakagawa T. Astroblastoma: immunohistochemical and ultrastructural study of distinctive epithelial and probable tanycytic differenriation. Neuropathology 2006; 26: 72-81.
20. Denaro L, Gardiman M, Calderone M etal. Intraventricular astroblastoma. J Neurosurg Pediatr 2008; 1: 152-155.
21. Eom K-S, Kim J-M, Kim T-Y. A cerebral astroblastoma mimicking an extra-axial neoplasm. J Korean Neurosurg Soc 2008; 43: 205-208.
22. Ohnishi A, Sawa H, Tsuda M etal. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in defferential types of human gliomas. J Neuropathol Exp Neurol 2003; 62: 1052-1059.
23. Ligon KL, Alberta JA, Kho AT etal. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004; 63: 499-509.
24. Otero JJ, Rowitch D, Vandenberg S. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasm. J Neurooncol 2011; 104: 423-438.
25. Hirano H, Yunoue S, Kaji M, Tsuchiya M, Arita K. Consecutive histological changes in an astroblastoma that disseminated to the spinal cord after repeated intracranial recurrences: a case report. Brain Tumor Pathol 2008; 25: 25-31.
26. Bergkasa M, Sundstrom S, Gulati S, Torp SH. Astroblastoma - a case report of a rare neuroepithelial tumor with complete remission after chemotherapy. Clin Neuropathol 2011; 30: 301-306.
27. Rubinstein LJ, Herman MM. The astroblastoma and its possible cytogenic relationship to the tanycyte. An electron microscopic, immunohistochemical, tissue- and organ-culture study. Acta Neuropathol 1989; 78: 472-483.
28. Sato K, Kubota T, Ishida M, Yoshida K, Takeuchi H, Handa Y. Immunohistochemical and ultrastructural study of chordoid glioma of the third ventricle: its tanycytic differentiation. Acta Neuropathol 2003; 106: 176-180.
29. Kawasaki K, Kohno M, Inenaga C etal. Chordoid glioma of the third ventricle: a report of two cases, one with ultrastructural findings. Neuropathology 2009; 29: 85-90.
30. Reifenberger G, Weber T, Weber RG etal. Chordoid glioma of the third ventricle: immunohistochemical and molecular genetic characterization of a novel tumor entity. Brain Pathol 1999; 9: 617-626.
31. Bannykh SI, Fan X, Black KL. Malignant astroblastoma with rhabdoid morphology. J Neurooncol 2007; 83: 277-278.
32. Fathi A-R, Novoa E, El-Koussy M, Kappeler A, Mariani L, Vajitai I. Astroblastoma with rhabdoid features and favorable long-term outcome: report of a case with a 12-year follow-up. Pathol Res Pract 2008; 204: 345-351.
33. Johnson KA, Bonnin JM, Boaz JC, Douglas-Akinwande AC, Hattab EM. Anaplastic astroblastoma presenting as massive, sudden-onset, intraparenchymal hemorrhage. Pediatr Neurosurg 2010; 46: 457-461.
34. Judkins AR, Eberhart CG, Wesseling PW. Atypical teratoid/rhabdoid tumor. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARCP, 2007; 147-149.
35. Inenaga C, Toyoshima Y, Mori H, Nishiyama K, Tanaka R, Takahashi H. A forth ventricle atypical teratoid/rhabdoid tumor in an infant. Brain Tumor Pathol 2003; 20: 47-52.
36. Ransom DT, Ritland SR, Moertel CA etal. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer 1992; 5: 357-374.
37. Shuangshoti S, Mitphraphan W, Kanvisetsri L etal. Astroblastoma: report of a case with microsatellite analysis. Neuropathology 2000; 20: 228-232.
38. Camelo-Piragua S, Jansen M, Ganguly A etal. A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53. J Neuropathol Exp Neurol 2011; 70: 110-115.
39. Capper D, Weissert S, Balss J etal. Characterization of R132 H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 2010; 20: 245-254.
40. Zhou Y-X, Wang J-X, Feng M etal. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma. J Mol Neurosci 2012; 47: 442-447.
41. Ichimura K, Pearson DM, Kocialkowski S etal. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol 2009; 11: 341-347.
42. McLendon RE, Wiester OD, Kros JM, Korshunov A, Ng H-K. Ependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARCP, 2007; 74-78.
43. Kujas M, Faillot T, Lalam T, Roncier B, Catala M, Poirier J. Astroblastoma revisited. Report of two cases with immunocytochemical and electron microscopic study. Histogenetic considerations. Neuropathol Appl Neurobiol 2000; 26: 295-298.